Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Building an interpretable machine learning prognosis prediction model-based on baseline examinations of patients with esophageal cancer undergoing surgery.

Created on 29 Aug 2026

Authors

Ruiyu Zhan, Qifeng Wang

Published in

Frontiers in oncology. Volume 16. Pages 1839382. Epub Aug 14, 2026.

Abstract

To create an interpretable machine learning model based on non-invasive biomarkers for the early diagnosis and improved prognostic value of esophageal cancer. We gathered a private dataset at Sichuan Cancer Hospital, comprising 3204 esophageal cancer patients who underwent surgery. Baseline markers and preoperative biochemical blood tests were thoroughly reviewed. The necessary factors were identified using an elastic net, and 27 machine learning methods were used to construct prediction models. The random forest model was chosen for its high performance, and additional optimization was performed using the White Shark Optimizer (WSO) algorithm. To improve the model's interpretability, the Shapley Additive exPlanations (SHAP) technique was used. We proposed an interpretable machine learning framework for exploratory early risk stratification of postoperative esophageal squamous cell carcinoma patients using routinely available preoperative baseline examinations. The random forest (RF) model achieved 0.74 accuracy and 0.72 F1 score after 1 year. It was adjusted to 0.69 in the Area Under the Curve (AUC). Gender and blood magnesium levels were the best six characteristics that affected the 1-year and 5-year survival rates. The model with the highest discriminative ability accurately predicted the prognosis of esophageal cancer patients in the test population. Our research led to the creation of a machine learning model that accurately predicts the prognosis of esophageal cancer and identifies early indicators of adverse outcomes. SHAP-improved interpretability facilitates physician-patient interaction and trust and promotes individualized therapy.

PMID:
42666217
Bibliographic data and abstract were imported from PubMed on 29 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement